CLINICAL_TRIALS
trial_result
· 2021-07-02
Clinical Trial Update: Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) [Phase 2]
Summary
Phase 2 trial update for AR-1105 in macular edema due to retinal vein occlusion has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aerie Pharmaceuticals | Conditions: Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2021-07-02